According to the analysis mentioned above, we believe that the initial treatment of patients with PTB who had malnutrition, microalbuminuria, hematuria, CA-125 positivity, and a high CYS-C value should not receive anti-TB immediately, supposing patients with PTB fail to improve their nutritional status and fail take measures to protect their kidney function in advance. This evidence concerns the gene MUC16 and malnutrition.